Indication
Chronic Kidney Failure
10 clinical trials
11 products
1 drug
Product
MK-2060Clinical trial
A Single-and Multiple Dose Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Subcutaneous MK-2060 in Participants With Chronic and/or End-Stage Kidney DiseaseStatus: Recruiting, Estimated PCD: 2024-07-05
Product
PlaceboProduct
Bardoxolone MethylClinical trial
A Phase 3, Prospective, Randomized, Multicenter, Single-blind, Controlled Study Evaluating Arteriovenous Fistula Outcomes With and Without a Perivascular Sirolimus Eluting Collagen Implant (The ACCESS 2 Trial)Status: Recruiting, Estimated PCD: 2024-03-01
Product
SirolimusClinical trial
A Randomized Parallel-group, Placebo-controlled, Double-blind, Event-driven, Multi-center Phase 2 Clinical Outcome Trial of Prevention of Arteriovenous Graft Thrombosis and Safety of MK-2060 in Patients With End Stage Renal Disease Receiving HemodialysisStatus: Active (not recruiting), Estimated PCD: 2024-07-10
Clinical trial
A Study to Evaluate Safety and Tolerability of Co-administration of MK-2060 and Clopidogrel in Participants With End-Stage Renal Disease on HemodialysisStatus: Completed, Estimated PCD: 2023-02-14
Clinical trial
A Phase I/II Trial to Evaluate the Safety and Tolerability of Clazakizumab (Anti-IL-6 Monoclonal) to Eliminate Donor Specific HLA Antibodies (DSAs) and Improve Transplant Rates in Highly-HLA Sensitized Patients Awaiting Renal TransplantStatus: Active (not recruiting), Estimated PCD: 2025-07-30
Product
ClazakizumabClinical trial
Once Daily Dosing to Improve Medication Adherence and Patient Satisfaction in Kidney Transplant Recipients: A Pilot StudyStatus: Active (not recruiting), Estimated PCD: 2022-08-10
Product
AdvagrafProduct
Conversion to once daily MPAClinical trial
A Phase 1 Interventional Study to Test Short-Term Safety, Tolerability and Preliminary Efficacy of Sodium-Free Intraperitoneal 30% Icodextrin/10% Dextrose Solution in Peritoneal Dialysis PatientsStatus: Completed, Estimated PCD: 2023-10-20
Product
Icodextrin/DextroseClinical trial
Belatacept as a Replacement for CNIs 3 to 12 Months Post-transplantation in Patients With Early Graft DysfunctionStatus: Recruiting, Estimated PCD: 2027-05-03
Product
BelataceptClinical trial
Anti-Cytokine Therapy for Hemodialysis InflammatION (ACTION): A Phase II Multi-center Study to Evaluate the Safety and Tolerability of Anakinra, an IL-1 Receptor Antagonist, for Patients Treated With Maintenance HemodialysisStatus: Completed, Estimated PCD: 2021-09-02
Product
AnakinraDrug
Varlilumab